Olympus (in partnership with Ziosoft)
About Olympus (in partnership with Ziosoft)
Olympus, in partnership with Ziosoft, has launched an AI-powered clinical decision tool designed to revolutionize pre-operative planning for surgeons. This collaboration integrates Ziosoft’s advanced imaging analytics and machine learning capabilities to transform traditional 2D CT/MRI images into precise, dynamic 3D models in real time. The goal is to empower surgeons with enhanced visualization and analytical tools, leading to greater diagnostic confidence, lower dose options, and improved precision in surgical and treatment planning.
This innovative application, notably utilizing Ziosoft’s Revoras platform, focuses on critical procedures in thoracic, liver, and urologic surgery. For thoracic surgery, it aids in lung cancer and other thoracic procedure planning by creating detailed 3D lung models. In liver surgery, it helps visualize liver anatomy, vessels, and tumors for liver-sparing resections. For urologic surgery, it assists in minimally invasive nephrectomies by accurately assessing tumor size, location, and shape. The technology aims to help physicians make more informed clinical decisions, optimize tissue sparing, improve tumor margins, and serve as a valuable educational resource for surgical fellows.
Focus Areas
Business Intelligence
| Partnerships | Ziosoft, HCLTech, Proximie |
| Acquisitions | Taewoong Medical (acquired by Olympus); Olympus divested its camera business to OM Digital Solutions and its microscopy division to Evident Corporation (acquired by Bain Capital) |
| Technology | Cloud-based AI, advanced imaging analytics, machine learning, 3D modeling, real-time image processing, vendor-neutral and multi-modality advanced visualization platform (Ziosoft's REVORAS/Ziostation2), Intelligent Endoscopy Ecosystem (Olympus OLYSENSE™) |
| FDA Clearances | Multiple AI-related FDA clearances, including Olympus's CADDIE™ for colorectal polyp detection and Ziosoft's REVORAS platform for 3D visualization and surgical planning. cleared products (estimated) |
What Physicians Need to Know
- Thoracic Surgery: Transforms 2D images into 3D models for lung cancer and thoracic procedure planning, aiming for less invasive approaches.
- Liver Surgery: Aids general and hepatobiliary surgeons in visualizing liver anatomy, practicing ahead, and planning liver-sparing surgeries to improve patient recovery.
- Urologic Surgery: Assists in minimally invasive nephrectomies by accurately assessing tumor size, location, and shape.
Olympus (in partnership with Ziosoft) stands out for physicians by offering tools that significantly enhance pre-operative planning through real-time 3D modeling, moving beyond traditional 2D imaging. This allows for improved surgical precision, aids in tissue-sparing techniques, and helps achieve better tumor margins. The AI-powered clinical decision support, including CADe/CADx in endoscopy, provides real-time assistance for diagnosis and treatment, potentially reducing unnecessary procedures and improving diagnostic confidence. Furthermore, the 3D modeling serves as a valuable educational resource for surgical fellows and newer surgeons, fostering a 'Seeing the Invisible' approach to make procedures safer, more efficient, and consistently successful. The collaboration combines Olympus's deep expertise in minimally invasive solutions with Ziosoft's proven AI software, offering a vendor-neutral and multi-modality platform designed to integrate seamlessly into existing workflows.
The Ziosoft Revoras platform is designed as a software-only, vendor-neutral, and multi-modality advanced visualization technology, aiming to minimize cost of ownership and facilitate integration with various imaging systems. The CADDIE AI System is a cloud-based AI endoscopy system, suggesting a flexible and accessible integration model. These solutions are part of Olympus's broader Intelligent Endoscopy Ecosystem, indicating a strategic approach to integrating AI with existing hardware, software, services, and data to create a cohesive and enhanced clinical environment.
What the Web Says
Olympus, in partnership with Ziosoft, recently launched an AI-powered clinical decision tool for surgical planning, focusing on thoracic, liver, and urologic procedures. This tool transforms 2D CT/MRI scans into 3D models to aid surgeons in preparation, aiming to enhance precision, streamline workflows, and improve patient outcomes. While this new product has been highlighted positively, general employer reviews for Olympus are mixed, with some employees praising work-life balance and benefits, while others express concerns about management, pay, and job security.
Overall: MixedStrengths
- AI-powered surgical planning tool enhances precision and streamlines workflows.
- Transforms 2D scans into dynamic 3D models for better surgical preparation.
- Potential to improve patient outcomes and spare healthy tissue.
- Can serve as an educational resource for surgical trainees.
- Good benefits and work-life balance reported by some Olympus employees.
- Olympus is a market leader in gastrointestinal endoscopic equipment.
Limitations
- Some Olympus scopes have been linked to superbug outbreaks due to design defects making them difficult to clean.
- Olympus has faced lawsuits and FDA scrutiny regarding scope-related infections.
- Concerns about management, low pay, and job security from some Olympus employees.
- Some Reddit users report negative experiences with Zio patches, citing skin irritation and device malfunction.
- Ziosoft's Revoras platform, while innovative, is a new launch, and long-term user reviews are not yet widely available.
Based on reviews from: Indeed.com, IT Tech Pulse, ICE Magazine, AuntMinnie, PR Newswire, Capterra, Reddit, Drugwatch.com, Los Angeles Times
Last updated: 2026-07-27
Videos
News, demos, and interviews about Olympus (in partnership with Ziosoft).
Videos load interactively. If none appear, search YouTube for Olympus (in partnership with Ziosoft) →
Press & Coverage
Frequently Asked Questions
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]